Skip to content
Altius – Lifestyle
Author:
ELI LILLY AND COMPANY
Lilly’s EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis
March 27, 2026
←
Previous Page
1
…
3
4
5